Nuwellis, Inc.
Close on Oct 19, 2026
- Market cap
- $101.13K
- P/E (TTM)
- –
- Dividend yield
- –
Earnings
Next report expected Nov 11, 2026, before market open (estimated from past report dates)
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q2 FY2026 Ended Jun 30, 2026 | Aug 13, 2026 | During market hours | $2.00M | – | – |
| Q1 FY2026 Ended Mar 31, 2026 | May 12, 2026 | During market hours | $2.40M | – | – |
| Q4 FY2025 Ended Dec 31, 2025 | Mar 10, 2026 | During market hours | $2.40M | $-1.50 | – |
| Q3 FY2025 Ended Sep 30, 2025 | Nov 12, 2025 | Before market open | $2.20M | $0.56 | – |
| Q2 FY2025 Ended Jun 30, 2025 | Aug 14, 2025 | Before market open | $1.70M | $-60.99 | – |
| Q1 FY2025 Ended Mar 31, 2025 | May 13, 2025 | Before market open | $1.90M | $-0.69 | – |
| Q4 FY2024 Ended Dec 31, 2024 | Mar 11, 2025 | Before market open | $2.30M | $-0.44 | – |
| Q3 FY2024 Ended Sep 30, 2024 | Nov 1, 2024 | During market hours | $2.40M | – | – |
| Q2 FY2024 Ended Jun 30, 2024 | Aug 13, 2024 | Before market open | – | – | – |
| Q1 FY2024 Ended Mar 31, 2024 | May 7, 2024 | Before market open | – | – | – |
| Q4 FY2023 Ended Dec 31, 2023 | Mar 6, 2024 | Before market open | – | – | – |
Press releases
Announcements Nuwellis filed with the SEC
August 2026 INVESTOR PRESENTATION NASDQ: NUWE
Regulation FD disclosure · EX-99.1 to Form 8-K
Nuwellis Reports Second Quarter 2026 Financial Results and Business Highlights Focused on Double Digit Revenue Growth and Expanded
Results of operations · EX-99.1 to Form 8-K
Nuwellis Announces Pricing of $3.4 Million Registered Direct Offering
Material agreement · Unregistered share sale · Other events · EX-99.1 to Form 8-K
Nuwellis Appoints Mike McCormick as Chief Executive Officer
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
Nuwellis Announces Closing of $6.0 Million Registered Public Offering
Regulation FD disclosure · EX-99.1 to Form 8-K
Nuwellis, Inc. Announces First Quarter 2026 Financial Results
Results of operations · EX-99.1 to Form 8-K
Nuwellis, Inc. Announces Fourth Quarter and Full Year 2025 Financial Results
Results of operations · EX-99.1 to Form 8-K
Minneapolis, MN – February 26, 2026
Executive or director change · Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
Nuwellis Announces $5 Million Private Placement and Warrant Inducement Transaction, Priced At-The-Market
Material agreement · Unregistered share sale · Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
Minneapolis, MN – January 29, 2026
Material agreement · Unregistered share sale · Executive or director change · Regulation FD disclosure · EX-99.2 to Form 8-K
Minneapolis, MN – January 30, 2026
Material agreement · Unregistered share sale · Executive or director change · Regulation FD disclosure · EX-99.3 to Form 8-K
Minneapolis, MN – January 23, 2026
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
Nuwellis Reports Third Quarter 2025 Results and Continued Operational Momentum
Results of operations · EX-99.1 to Form 8-K
Nuwellis, Inc. Reports Second Quarter 2025
Results of operations · EX-99.1 to Form 8-K
Nuwellis, Inc. Announces First Quarter 2025 Financial Results and Business Highlights
Results of operations · EX-99.1 to Form 8-K
Investor Presentation April 2025 Making Aquadex the Standard of Care for
Regulation FD disclosure · EX-99.1 to Form 8-K
Nuwellis, Inc. Announces Fourth Quarter and Full Year 2024 Financial Results
Results of operations · EX-99.1 to Form 8-K
Minneapolis, MN – February 24, 2025
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
Nuwellis Regains Compliance with Nasdaq Listing Requirements
Other events · EX-99.1 to Form 8-K
Nuwellis, Inc. Announces Third Quarter 2024 Financial Results and Recent Highlights
Results of operations · EX-99.1 to Form 8-K
Nuwellis Announces Exercise of Warrants for $5.1 Million of Gross Proceeds
Material agreement · Unregistered share sale · Other events · EX-99.1 to Form 8-K
Nuwellis Announces Preliminary Results for Third Quarter of 2024
Results of operations · EX-99.1 to Form 8-K
Announces Pricing of $916,000 Registered Direct Offering
Material agreement · Unregistered share sale · Regulation FD disclosure · EX-99.1 to Form 8-K
Nuwellis, Inc. Announces Second Quarter 2024 Financial Results
Results of operations · EX-99.1 to Form 8-K
Nuwellis Announces Pricing of $2.0 Million Offering
Material agreement · Unregistered share sale · Regulation FD disclosure · EX-99.1 to Form 8-K
Aquadex FlexFlow® and Aquadex SmartFlow® are registered trademarks of Nuwellis,
Other events · EX-99.1 to Form 8-K/A
Nuwellis Marks First Commercial Sale of QUELIMMUNE™ Therapy to Cincinnati Children’s
Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
Aquadex FlexFlow® and Aquadex SmartFlow® are registered trademarks of Nuwellis,
Other events · EX-99.1 to Form 8-K
Nuwellis Announces Reverse Stock Split
Charter or bylaw amendment · Regulation FD disclosure · EX-99.1 to Form 8-K
Nuwellis and DaVita Extend Supply and Collaboration Agreement Pilot Phase
Material agreement · Other events · EX-99.1 to Form 8-K
Nuwellis, Inc. Announces First Quarter 2024 Financial Results
Results of operations · EX-99.1 to Form 8-K
Nuwellis Announces Pricing of $2.7 Million Public Offering
Material agreement · Other events · EX-99.1 to Form 8-K
Nuwellis Announces Closing of $2.7 Million Public Offering
Material agreement · Other events · EX-99.2 to Form 8-K
Nuwellis, Inc. Announces Fourth Quarter and Full Year 2023 Financial Results
Results of operations · EX-99.1 to Form 8-K
New Case Series Demonstrates Potential of Aquadex Therapy for End-Stage Liver Disease Patients with Fluid Overload
Other events · EX-99.1 to Form 8-K
1 | FOR INVESTOR PURPOSES ONLY: NOT FOR PRODUCT PROMOTION ©2024 Nuwellis,
Regulation FD disclosure · EX-99.1 to Form 8-K/A
1 | FOR INVESTOR PURPOSES ONLY: NOT FOR PRODUCT PROMOTION ©2024 Nuwellis,
Regulation FD disclosure · EX-99.1 to Form 8-K
Nuwellis, Inc. Announces Third Quarter 2023 Financial Results
Results of operations · EX-99.1 to Form 8-K
Nuwellis Announces Pricing of $2.25 Million Public Offering of Series J Convertible Redeemable Preferred Stock and Warrants
Material agreement · Charter or bylaw amendment · Other events · EX-99.1 to Form 8-K
Nuwellis Announces Closing of $2.25 Million Public Offering of Series J Convertible Redeemable Preferred Stock and Warrants
Material agreement · Charter or bylaw amendment · Other events · EX-99.2 to Form 8-K